Page last updated: 2024-08-23

cicletanine and furosemide

cicletanine has been researched along with furosemide in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caron, G; Ermondi, G1
Berthet, P; Braquet, P; Esanu, A; Koltai, M; Tarrade, T; Tosaki, A1
Andries, R; Bourgain, RH; Deby, C1
Bourgain, RH; Braquet, P; Deby, C; Deby-Dupont, G; Garay, RP; Pincemail, J1
Bourgain, RH; Deby, C1
Leary, WP; Reyes, AJ1
Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R1
Bassett, K; Jauca, CD; Musini, VM; Rezapour, P; Wright, JM1

Reviews

2 review(s) available for cicletanine and furosemide

ArticleYear
Clinicopharmacological reappraisal of the potency of diuretics.
    Cardiovascular drugs and therapy, 1993, Volume: 7 Suppl 1

    Topics: Clopamide; Diuretics; Furosemide; Humans; Hydrochlorothiazide; Muzolimine; Natriuresis; Pyridines; Sulfonamides; Torsemide; Xipamide

1993
Blood pressure-lowering efficacy of loop diuretics for primary hypertension.
    The Cochrane database of systematic reviews, 2015, May-22, Issue:5

    Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Furosemide; Humans; Hypertension; Indans; Pyridines; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Thiazoles

2015

Other Studies

6 other study(ies) available for cicletanine and furosemide

ArticleYear
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water

2005
Effect of cicletanine on reperfusion-induced arrhythmias and myocardial ion contents: a comparison with furosemide.
    European heart journal, 1992, Volume: 13, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Body Water; Diuretics; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrolytes; Furosemide; Heart; Male; Myocardial Reperfusion; Myocardium; Pyridines; Rats; Rats, Inbred WKY

1992
[Effect of cicletanine on prostacyclin generation in vivo].
    Archives des maladies du coeur et des vaisseaux, 1989, Volume: 82 Spec No 4

    Topics: Animals; Diuretics; Epoprostenol; Furosemide; Pyridines; Rabbits; Rats; Rats, Inbred Strains; Thromboxane A2; Tranylcypromine

1989
Modulation of in vivo generation of prostanoids by drugs affecting membrane ion transport.
    Drugs under experimental and clinical research, 1988, Volume: 14, Issue:2-3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Bumetanide; Diuretics; Ethylmaleimide; Furosemide; Insulin; Male; Models, Biological; Potassium; Prostaglandin-Endoperoxide Synthases; Pyridines; Rabbits; Thromboxane B2; Time Factors; Verapamil

1988
Enhancement of prostacyclin generation by cicletanine (an in vivo investigation).
    Drugs under experimental and clinical research, 1988, Volume: 14, Issue:2-3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Cytochrome P-450 Enzyme System; Diuretics; Epoprostenol; Furosemide; Intramolecular Oxidoreductases; Isomerases; Pyridines; Rabbits; Rats; Thromboxane A2; Thromboxane B2; Tranylcypromine

1988
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-10, Volume: 130, Issue:23

    Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents

2005